220 related articles for article (PubMed ID: 37841571)
1. Signaling by Ion Channels: Pathways, Dynamics and Channelopathies.
Dai G
Mo Med; 2023; 120(5):367-373. PubMed ID: 37841571
[TBL] [Abstract][Full Text] [Related]
2. Defective interactions of protein partner with ion channels and transporters as alternative mechanisms of membrane channelopathies.
Kline CF; Mohler PJ
Biochim Biophys Acta; 2014 Feb; 1838(2):723-30. PubMed ID: 23732236
[TBL] [Abstract][Full Text] [Related]
3. Neurological channelopathies.
Kullmann DM
Annu Rev Neurosci; 2010; 33():151-72. PubMed ID: 20331364
[TBL] [Abstract][Full Text] [Related]
4. Ion Transporters, Channelopathies, and Glucose Disorders.
Demirbilek H; Galcheva S; Vuralli D; Al-Khawaga S; Hussain K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137773
[TBL] [Abstract][Full Text] [Related]
5. Ion channelopathies to bridge molecular lesions, channel function, and clinical therapies.
Carbone E; Mori Y
Pflugers Arch; 2020 Jul; 472(7):733-738. PubMed ID: 32607810
[No Abstract] [Full Text] [Related]
6. The channelopathies: novel insights into molecular and genetic mechanisms of human disease.
Kass RS
J Clin Invest; 2005 Aug; 115(8):1986-9. PubMed ID: 16075038
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune channelopathies in paraneoplastic neurological syndromes.
Joubert B; Honnorat J
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
[TBL] [Abstract][Full Text] [Related]
8. Mechanically activated ion channels.
Martinac B; Poole K
Int J Biochem Cell Biol; 2018 Apr; 97():104-107. PubMed ID: 29471041
[TBL] [Abstract][Full Text] [Related]
9. Channelopathies of transepithelial transport and vesicular function.
Hübner CA; Jentsch TJ
Adv Genet; 2008; 63():113-152. PubMed ID: 19185187
[TBL] [Abstract][Full Text] [Related]
10. Relevance of tissue specific subunit expression in channelopathies.
Seitter H; Koschak A
Neuropharmacology; 2018 Apr; 132():58-70. PubMed ID: 28669898
[TBL] [Abstract][Full Text] [Related]
11. Ion Channels as Therapeutic Targets for Viral Infections: Further Discoveries and Future Perspectives.
Charlton FW; Pearson HM; Hover S; Lippiat JD; Fontana J; Barr JN; Mankouri J
Viruses; 2020 Aug; 12(8):. PubMed ID: 32756358
[TBL] [Abstract][Full Text] [Related]
12. Ion channel pharmacology.
Camerino DC; Tricarico D; Desaphy JF
Neurotherapeutics; 2007 Apr; 4(2):184-98. PubMed ID: 17395128
[TBL] [Abstract][Full Text] [Related]
13. The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets.
Maqoud F; Tricarico D; Mallamaci R; Orlando A; Russo F
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446251
[TBL] [Abstract][Full Text] [Related]
14. Channelopathies go above and beyond the channels.
Schorge S
Neuropharmacology; 2018 Apr; 132():1-2. PubMed ID: 29454019
[No Abstract] [Full Text] [Related]
15. Contribution of Axon Initial Segment Structure and Channels to Brain Pathology.
Garrido JJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190119
[TBL] [Abstract][Full Text] [Related]
16. Physiologic principles underlying ion channelopathies.
Cannon SC
Neurotherapeutics; 2007 Apr; 4(2):174-83. PubMed ID: 17395127
[TBL] [Abstract][Full Text] [Related]
17. Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus.
Selvaraj C; Selvaraj G; Kaliamurthi S; Cho WC; Wei DQ; Singh SK
Curr Drug Targets; 2020; 21(2):132-147. PubMed ID: 31538892
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial channelopathies in aging.
Pi Y; Goldenthal MJ; Marín-García J
J Mol Med (Berl); 2007 Sep; 85(9):937-51. PubMed ID: 17426949
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitylation and SUMOylation of cardiac ion channels.
Rougier JS; Albesa M; Abriel H
J Cardiovasc Pharmacol; 2010 Jul; 56(1):22-8. PubMed ID: 20224423
[TBL] [Abstract][Full Text] [Related]
20. Ion Channel Disorders and Sudden Cardiac Death.
Garcia-Elias A; Benito B
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
